The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
TREM2 — a key player in microglial biology and Alzheimer disease
Abstract
Alzheimer disease (AD) is a debilitating dementia believed to result from the deposition of extracellular amyloid-β (Aβ)-containing plaques followed by the formation of neurofibrillary tangles. Familial AD typically results from mutations in the genes encoding amyloid precursor protein (APP), presenilin 1 or presenilin 2. Variations in triggering receptor expressed on myeloid cells 2 (TREM2), one of several genes for which expression is restricted to microglia in the brain, have now been shown to increase the risk of developing late-onset AD. Microglia have been shown to respond to Aβ accumulation and neurodegenerative lesions, progressively acquiring a unique transcriptional and functional signature and evolving into disease-associated microglia (DAM). DAM attenuate the progression of neurodegeneration in certain mouse models, but inappropriate DAM activation accelerates neurodegenerative disease in other models. TREM2 is essential for maintaining microglial metabolic fitness during stress events, enabling microglial progression to a fully mature DAM profile and ultimately sustaining the microglial response to Aβ-plaque-induced pathology. Here, we review the current data detailing the role of TREM2 in microglial biology and AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREM2 engagement with ligands triggers the phosphorylation of the DAP12 ITAM, subsequently initiating a cascade of activation of downstream kinases, such as AKT, MAPK, and mTOR29,30.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [30]
In the citing paper
“These kinases are centrally involved in controlling cell metabolism, survival, proliferation, and phagocytosis29,30.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [30]
In the citing paper
“TREM2 engagement leads to DAP12 phosphorylation, followed by recruitment and activation of the spleen-associated tyrosine kinase (SYK), resulting in downstream signaling events leading to proliferation, survival, phagocytosis, and secretion of cytokines and chemokines [47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“The general consensus is that TREM2 is expressed by microglia in the CNS, especially after activation [6, 21, 47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“TREM2 binds on the membrane to the DNAX-activation protein 12 (DAP12) which is an adaptor protein required for TREM2 surface expression and intracellular signaling [47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“In comparison to previous studies which are aligned to the concept that suppressing microglial function may be beneficial in the setting of AD [49], the data described here, together with studies on TREM2 and other AD-associated variants, suggest that a different directionality may be therapeutically useful [6, 46, 50].”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [46]
In the citing paper
“One receptor acting upstream of Plcg2 and evoking such responses in innate immune cells might be Trem2 [17, 46].”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [46]
In the citing paper
“TREM2 is one of the key receptors modulating PLCγ2 activity [12, 36, 37].”
From Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers (2026) · cites this paper as [36]
In the citing paper
“Although TREM2 is expressed on the cell surface, it is cleaved from the cell surface by metalloproteases and released as soluble TREM2 (sTREM2) (Ulland and Colonna, 2018).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“TREM2 has been extensively studied in microglia for its capacity to sustain microglial responses to neurodegenerative pathologies such as Alzheimer’s disease (Ulland and Colonna, 2018).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“This could be representative of changes in TREM2 expression or shedding, both of which are altered during ageing and disease [55], thereby reducing TREM2-mediated signalling and subsequent conversion of microglia to DAM [56].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [56]
In the citing paper
“Rac is known to be activated downstream of TREM2/DAP12 via Syk and Vav2/3 activation [56].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [56]
In the citing paper
“Mutations affecting the TREM2 function impair microglial activation (37) and reduce their ability to accumulate LDs in the AD brain (38).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [37]
In the citing paper
“Loss-of-function (LOF) variants of TREM2, an immune receptor expressed in microglia, increase Alzheimer’s disease risk.”
From TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“Certain TREM2 LOAD variants, including R47H, show reduced affinity to lipids”
From TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“Most notably, a hypomorphic variant in the microglial receptor TREM2, R47H, increases the risk of AD several fold, as do other TREM2 variants, such as R62H, although with reduced penetrance14.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [14]
In the citing paper
“AD patients carrying the R47H variant, who have a higher risk (2-4-fold) of developing AD than do R62H carriers.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [14]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Self-citation2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Research works printed but not linked: 3
- Nissl, F. in Histologische und histopathologische Arbeiten über die Grosshirnrinde Vol. 1 (eds. Nissl, F., Alzheimer, A.) 315–494 (G. Fischer, Jena, Germany, 1904).
- Alzheimer, A. in Histologische und histopathologische Arbeiten über die Grosshirnrinde Vol. 3 (eds. Nissl, F., Alzheimer, A.) 401–562 (G. Fischer, Jena, Germany, 1910).
- Hortega, P. R. El tercer elemento de los centros nerviosos. III. Naturaleza probable de la microglía [Spanish]. Bol. Soc. Esp. Biol. 8, 108–115 (1919).
Cited by
Sorted by citations
Items 401–500 of 737
Glial cells in the mammalian olfactory bulb
Zhao, D., Hu, M., & Liu, S. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1426094 · Cited by 11
Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review
Islam, M. R., Rabbi, M. A., Hossain, T., Sultana, S., & Uddin, S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00360 · Cited by 10
Lin, D., Kaye, S. D., Chen, M., Lyanna, A., Ye, L., Hammond, L. A., & Gao, J. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107874 · Cited by 12
TREM 2 in Parkinson’s Disease: A Promising Candidate Gene for Disease Susceptibility and Progression
Alonge, P., Balistreri, C. R., Angelo, T., Magro, D., Rubino, E., & Monastero, R. (2025) · Brain Sciences · doi:10.3390/brainsci15040379 · Cited by 10
Neuroinflammation als Motor der Alzheimer-Erkrankung
Castro‐Gomez, S., Binder, J., & Heneka, M. T. (2019) · Der Nervenarzt · doi:10.1007/s00115-019-0778-3 · Cited by 11
Nájera, G. S., Narganes-Carlón, D., & Crowther, D. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-94897-9 · Cited by 9
Hu, H., Mei, J., Cai, Y., Ding, H., Niu, S., Zhang, W., & Fang, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1090223 · Cited by 10
Modeling neurodegenerative diseases using non-human primates: advances and challenges
Li, B., He, D., Li, X., & Guo, X. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.14 · Cited by 11
Rahimpour, S., Clary, B. L., Nasoohi, S., Berhanu, Y. S., & Brown, C. M. (2024) · Aging and Disease · doi:10.14336/ad.2024.1293 · Cited by 13
Xiao, X., Zhang, L. Y., Zhao, H., & Wang, Z. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-025-01161-0 · Cited by 12
He, L., Palos-Jasso, A., Yao, Y., Qin, M., Qiu, L., Yang, X., Zhang, Y., & Yu, J. (2022) · Cells · doi:10.3390/cells11243976 · Cited by 9
Interrogation of human microglial phagocytosis by CRISPR genome editing
Chang, J. C.-Y., Wang, C., & Lin, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1169725 · Cited by 9
Friends and Foes in Alzheimer’s Disease
Pauwels, E. K. J., & Boer, G. J. (2023) · Medical Principles and Practice · doi:10.1159/000534400 · Cited by 10
Velez, J. I., Samper, L. A., Arcos-Holzinger, M., Espinosa, L. G., Isaza-Ruget, M. A., Lopera, F. J., & Arcos‐Burgos, M. (2021) · Diagnostics · doi:10.3390/diagnostics11050887 · Cited by 9
Yılmaz, C., Rogdakis, T., Latorrata, A., Thanou, E., Karadima, E., Papadimitriou, E., Siapi, E., Li, K. W., Κάτσιλα, Θ., Calogeropoulou, T., et al. (2022) · Biomolecules · doi:10.3390/biom12030424 · Cited by 10
Savonenko, A. V., Wong, P. C., & Li, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00022-8 · Cited by 8
Schwarz, H., Bässler, S., Balta, D., Socher, E., Zunke, F., & Arnold, P. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113977 · Cited by 8
A TREM2 antibody energizes microglia
Zhao, N., & Bu, G. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01265-z · Cited by 8
Mechanisms of increased Alzheimer’s disease pathology with R47H and R62H TREM2 variants
Fancy, N. N., Willumsen, N., Chau, V. M. N., Boulger, S. L., Whitwell, H. J., Wang, W., Avot, B., Thomas, M., Talbot-Martin, J., Tsartsalis, S., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03036-z · Cited by 8
Lloyd, A. F., Martínez‐Muriana, A., Davis, E., Daniels, M. J. D., Hou, P., Mancuso, R., Brenes, A. J., Geric, I., Snellinx, A., Craessaerts, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.07.498804 · Cited by 9
Mihori, S., Nichols, F. C., Provatas, A. A., Matz, A., Zhou, B., Blesso, C. N., Panier, H. A., Daddi, L., Zhou, Y., & Clark, R. B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1415565 · Cited by 8
Enhancing gene set overrepresentation analysis with large language models
Zhu, J., Wang, R. Y., Wang, X., Azevedo, R., Moreno, A., Kuhn, J., & Khan, Z. (2024) · Bioinformatics Advances · doi:10.1093/bioadv/vbaf054 · Cited by 8
Ruan, E., Lin, J., Zhao, C., Sheng, Q., Chen, L., He, J., Duan, X., Qin, Y., Xing, T., Yang, S., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci178349 · Cited by 8
Neural Circuit Mapping and Neurotherapy-Based Strategies
Marei, H. E. S. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01595-5 · Cited by 13
Repopulation of microglia and its implications for CNS disorders: Insights from the single-cell era
Chen, C., Qiao, G., Tang, D., Xu, F., Dong, J., Zhang, J., & Jin, B. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107066 · Cited by 8
A neuroimmune cerebral assembloid model to study the pathophysiology of familial Alzheimer’s disease
Becerra-Calixto, A., Banerjee, A., Fan, H., Tan, C., Lee, E., McCullough, L. D., & Lee, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03544-x · Cited by 10
Tian, S., Liu, Y., Hong, H., & Li, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05280-y · Cited by 8
The cGAS–STING Pathway in Dementia: An Emerging Mechanism of Neuroinflammation
Min, Y., Lee, Y.-S., Lee, J.-W., Keum, D.-Y., Gwag, J.-Y., Jeon, S., Jo, H., & Kang, S.-U. (2025) · Brain Sciences · doi:10.3390/brainsci15111241 · Cited by 8
Emerging non-proinflammatory roles of microglia in healthy and diseased brains
Sun, Y., Che, J., & Zhang, J. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110664 · Cited by 10
García‐Alberca, J. M., de Rojas, I., Sánchez‐Mejías, E., Garrido-Martín, D., Gonzalez-Palma, L., Jiménez, S., Pino‐Ángeles, A., Cruz-Gamero, J. M., Mendoza, S., Alarcón‐Martín, E., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231150 · Cited by 9
Mazahir, F., Alam, M. I., & Yadav, A. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102318 · Cited by 9
Hsiao, Y.-C., Wallweber, H. A., Alberstein, R. G., Lin, Z., Du, C., Etxeberría, A., Aung, T., Shang, Y., Seshasayee, D., Seeger, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52442-y · Cited by 8
TREM2 activation promotes remyelination
Wood, H. B. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0404-9 · Cited by 8
Qin, C., Li, Y., & Wang, K. (2021) · Cells · doi:10.3390/cells10102757 · Cited by 8
Hu, S., Pan, N., Liu, C., Wang, Y., & Zhang, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.775432 · Cited by 8
Yamagishi, S., Iga, Y., Ikegaya, S., Kakiuchi, T., Ohba, H., Nishiyama, S., Fukomoto, D., Kanazawa, M., Harada, N., Tsukada, H., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02343-4 · Cited by 7
Zhang, X., Du, Y., Xiong, W., & Shang, P. (2022) · Medical Oncology · doi:10.1007/s12032-022-01885-8 · Cited by 8
Qiu, Z., Wang, H., Qu, M., Zhu, S., Zhang, H., Liao, Q., & Miao, C. (2023) · Brain Sciences · doi:10.3390/brainsci13010126 · Cited by 8
Gu, D., Wang, L., Zhang, N., Wang, H., & Yu, X. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02750-9 · Cited by 9
Schoenberg, P. L. A., Song, A. K., Mohr, E., Rogers, B. P., Peterson, T. E., & Murphy, B. A. (2023) · Human Brain Mapping · doi:10.1002/hbm.26491 · Cited by 8
Discovery and Evaluation of Novel Ship-1 Inhibitors
Miao, J., Lin, J., Dong, J., Amarasinghe, O., Mason, E. R., Chu, S., Qu, Z., Cullers, C. C., Putt, K. S., & Zhang, Z. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117965 · Cited by 7
Alonaizan, R., Alotaibi, W. K., Alsulami, A., Alkhulaifi, F. M., & Alomar, S. Y. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2440006 · Cited by 8
Non-Drug and Non-Invasive Therapeutic Options in Alzheimer’s Disease
Şovrea, A. S., Boşca, A. B., Dronca, E., Constantin, A.-M., Crintea, A., Suflețel, R. T., Lupean, R.-A., Ștefan, P.-A., Onofrei, M. M., Tschall, C., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13010084 · Cited by 9
PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases
Shi, Y., Hou, W., Li, B., & Zhu, C. (2025) · Communications Biology · doi:10.1038/s42003-025-08272-9 · Cited by 9
Abe, Y., Spann, N. J., Tang, W., Zeng, F., Seymour, C., Jansky, S., Guo, J. L., Huff, R. M., Chanthavixay, K., Richard, J. L. C., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02217-4 · Cited by 7
Gallo, C., Verrillo, L., Manzo, E., Cauzzi, E., Barbera, L. L., Sabatino, G., Paolis, M. L. D., Sciacca, M. F. M., Barra, G., Peroni, E., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03634-w · Cited by 8
Microglial Pten safeguards postnatal integrity of the cortex and sociability
Zhou, X., Wei, J., Li, L., Shu, Z., You, L., Liu, Y., Zhao, R., Yao, J., Wang, J., Luo, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1059364 · Cited by 7
CD33 Ameliorates Surgery-Induced Spatial Learning and Memory Impairments Through TREM2
Zou, J., Wang, Y., Zhang, X., Pan, X., Fang, T., Cai, D., Guo, L., Li, Y., He, Y., & Cao, X. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04410-2 · Cited by 8
Calcium Signalling in Microglia
Garaschuk, O., & Verkhratsky, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_7 · Cited by 7
Bhattarai, S., Kadry, R., Yeapuri, P., Lu, Y., Foster, E. G., Zhang, C., Dash, P. K., Poluektova, L. Y., Gorantla, S., Mosley, R. L., et al. (2025) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2024-0018 · Cited by 7
Moura, S., Nasciben, L. B., Ramírez, A. M., Coombs, L. E., Rivero, J., Booven, D. J. V., DeRosa, B. A., Hamilton‐Nelson, K. L., Whitehead, P. L., Adams, L. D., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70031 · Cited by 6
Non-Communicable Neurological Disorders and Neuroinflammation
Ballerini, C., NJAMNSHI, A. K., Juliano, S. L., Kalaria, R. N., Furlan, R., & Akinyemi, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.834424 · Cited by 7
Mathioudakis, L., Dimovasili, C., Bourbouli, M., Latsoudis, H., Kokosali, E., Gouna, G., Vogiatzi, E., Basta, M., Kapetanaki, S., Panagiotakis, S., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.07.002 · Cited by 7
CCR5 regulates Aβ1-42-induced learning and memory deficits in mice
Huang, H.-Y., Salinas, S., Cornell, J. L., Udoh, I.-B., Shen, Y., & Zhou, M. (2024) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2024.107890 · Cited by 7
Bianco, V., Svecla, M., Vingiani, G. B., Kolb, D., Schwarz, B., Buerger, M., Beretta, G., Norata, G. D., & Kratky, D. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00082 · Cited by 7
Race and Alzheimer Disease Biomarkers: A Neglected Race
Lleó, A., & Suárez-Calvet, M. (2021) · Neurology Genetics · doi:10.1212/nxg.0000000000000574 · Cited by 5
Yu, Y., Wang, S., Li, J., Yu, M., McCrocklin, K., Kang, J., Ma, A., Ma, Q., Xu, D. H., & Wang, J. (2025) · Nature Communications · doi:10.1038/s41467-025-63141-7 · Cited by 5
Tsui, J. S. M., Au, D. M., Uhm, H., Wong, W., Lo, R. M. N., Jiang, Y., Ip, F. C. F., Mok, K. Y., Wong, H. Y., Kwok, T. C. Y., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70586 · Cited by 7
Sharma, A., & Singh, T. G. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150047 · Cited by 7
The Role of TREM2 After Stroke: From Mechanisms to Therapeutic Potential
Zhou, T., Chen, A., Sun, Y., Huang, B., Xu, Y., & He, Q. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05622-w · Cited by 6
Singh, A. S., Naqvi, A. R., & Chanu, M. T. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.01.050 · Cited by 7
Bello, E., Long, K. R., Iwama, S., Steer, J., Cooper, S., Alasoo, K., Kumasaka, N., Schwartzentruber, J., Panousis, N. I., & Bassett, A. R. (2026) · iScience · doi:10.1016/j.isci.2026.115688 · Cited by 7
Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model
Chen, X., Li, K., Liu, S., Zhao, J., Tiwari, S., Zeng, F., ZHAO, Y., Zhang, P., Tang, H., Zhao, H., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2523148123 · Cited by 7
Kloske, C. M., Mahinrad, S., Barnum, C. J., Batista, A. F., Bradshaw, E. M., Butts, B., Carrillo, M. C., Chakrabarty, P., Chen, X., Craft, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14291 · Cited by 6
Genetic and expression analysis of COPI genes and Alzheimer’s disease susceptibility
Yang, Y., Wang, X., Ju, W., Sun, L., & Zhang, H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00866 · Cited by 6
Worthmann, A., & Heeren, J. (2020) · Immunometabolism · doi:10.20900/immunometab20200014 · Cited by 5
Pissarek, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100925 · Cited by 6
Goldstein, M. R., & Cheslock, M. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110645 · Cited by 8
The engagement of microglia in tau-targeted immunotherapy in Alzheimer’s disease
Palova, D., Csokova, N. T., Markova, K., Kontseková, E., Kováčech, B., & Žilková, M. (2021) · General Physiology and Biophysics · doi:10.4149/gpb_2021029 · Cited by 6
miRNA-Based Signature to Predict the Development of Alzheimer’s Disease
Chen, L., Zhan, F., Yang, J., & Lin, S. (2022) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207325666220208122911 · Cited by 5
Weathered, C., Bardehle, S., Yoon, C., Kumar, N. N., Leyns, C. E. G., Kennedy, M. E., Bloomingdale, P., & Pienaar, E. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13095 · Cited by 6
Karsak, M., Glebov, K., Scheffold, M., Bajaj, T., Kawalia, A., Karaca, I., Rading, S., Kornhuber, J., Peters, O., Díez-Fairén, M., et al. (2019) · Human Mutation · doi:10.1002/humu.23904 · Cited by 6
Screening for Core Genes Related to Pathogenesis of Alzheimer’s Disease
Yang, L.-X., Qin, Y. H., & Jian, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.668738 · Cited by 7
A Systematic Review of Updated Mechanistic Insights Towards Alzheimer’s Disease
Mittal, A., Sharma, R., Sardana, S., Goyal, P. K., Piplani, M., & Pandey, A. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220510144127 · Cited by 6
Zheng, Q., Han, Y., Fan, M., Gao, X., Ma, M., Xu, J., Liu, S., & Ge, J. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11904 · Cited by 6
Warwick, A., Hingorani, A. D., Khawaja, A. P., Gordillo‐Marañón, M., Olvera‐Barrios, A., Stuart, K. V., Egan, C. A., Tufail, A., Sofat, R., Kuan, V., et al. (2024) · medRxiv · doi:10.1101/2024.07.11.24310200 · Cited by 4
Boreland, A. J., Abbo, Y., Li, X., Stillitano, A. C., Zhang, S., Duan, J., Pang, Z. P., & Hart, R. P. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.10.006 · Cited by 8
Akinluyi, E. T., Takahashi, K., Connolly, M. G., Poon, W. W., & Macauley, M. S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00805 · Cited by 5
Immuno‐Regulation of Brain Region‐Specific Organoids Containing Isogenic Microglia‐Like Cells
Liu, C., Ene, J., Lü, W., Syed, F., Sun, L. J., Raulin, A., Ren, Y., Wang, X. S., Kanekiyo, T., & Li, Y. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503579 · Cited by 5
Liu, R., Deng, Q., Gong, L., & Yang, L. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01598-2 · Cited by 5
Yagi, H., Boeck, M., Neilsen, K., Yang, J., Ko, M., Tomita, Y., Negishi, K., Fu, Z., Sun, Y., & Smith, L. E. H. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321809 · Cited by 6
Zheng, N., Wang, Z., Cao, J., Li, K., Xu, H., Wang, J., Zhang, L., Meng, J., Tang, Z., Luo, H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70369 · Cited by 5
Lee, J., Sim, S., Jin, Y., Park, H., Byeon, E. Y., Kim, S. J., Yun, S., Lee, H., Jeong, D. U., Suh, J. M., et al. (2025) · Advanced Science · doi:10.1002/advs.202505495 · Cited by 5
Honig, M. G., Mar, N. A. D., Henderson, D. L., O’Neal, D., Yammanur, M., Cox, R., Li, C., Perry, A. M., Moore, B. M., II, & Reiner, A. J. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.108966 · Cited by 5
Chong, Z. Z., Menkes, D. L., & Souayah, N. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2023-0060 · Cited by 6
Towards a structural and functional analysis of the immunoglobulin-fold proteome
Tawfeeq, C., Song, J., Khaniya, U., Madej, T., Wang, J., Youkharibache, P., & Abrol, R. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.11.002 · Cited by 5
Hiding in plain sight: Do recruited dendritic cells surround amyloid plaques in Alzheimer’s disease?
Nelson, R. B., Rose, K. N., Menniti, F. S., & Zorn, S. H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116258 · Cited by 5
Shanmukha, S., Godfrey, W. H., Gharibani, P. M., Lee, J. J., Guo, Y., Deng, X., Wender, P. A., Kornberg, M. D., & Kim, P. M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1373557 · Cited by 5
TREM1 Blockade: Killing Two Birds with One Stone
Colonna, M. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.07.008 · Cited by 5
Self-citationAltered lipid metabolic homeostasis in the pathogenesis of Alzheimer’s disease
Marian, O. C., Tran, C., & Don, A. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00023-3 · Cited by 5
Astrocyte interleukin-3 preps microglia
Klein, R. S. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.09.008 · Cited by 5
Sánchez, K. E., Bhaskar, K., & Rosenberg, G. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.976108 · Cited by 7
Fu, X., Chen, S., Lian, H.-W., Deng, Y., Duan, R., Zhang, Y., & Jiang, T. (2023) · Brain Sciences · doi:10.3390/brainsci13040642 · Cited by 5
TREM2 R47H exacerbates immune response in Alzheimer’s disease brainPreprint
Korvatska, O., Kiianitsa, K., Ratushny, A., Matsushita, M., Beeman, N., Chien, W.-M., Satoh, J.-I., Dorschner, M., Keene, C., Bammler, T., et al. (2018) · bioRxiv · doi:10.1101/499319 · Cited by 4
Jiang, L., Roberts, R., Wong, M., Zhang, L., Webber, C. J., Kilci, A., Jenkins, M., Sun, G., Rashad, S., Sun, J., et al. (2023) · Research Square · doi:10.1101/2023.03.28.534515 · Cited by 5
Gao, C., Lin, Z., Chen, Y., Gan, R., Wang, K., He, X., & Han, H. (2025) · Neuropharmacology and Therapy · doi:10.15212/npt-2025-0015 · Cited by 5
Somodji, E. A., & Gowrishankar, S. (2026) · npj Dementia · doi:10.1038/s44400-026-00086-8 · Cited by 6
TREM2 Activation Relieves TMJOA by Stabilizing the Synovial Barrier via Siglec1
Liu, X., Luo, X., Xiao, M., Zhao, J., Fang, W., Ke, J., & Long, X. (2025) · Journal of Dental Research · doi:10.1177/00220345251320946 · Cited by 4
Fan, Y., Wang, X., Ling, Y., Wang, Q., ZHOU, X., Li, K., & ZHOU, C. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108475 · Cited by 4
O’Reilly, M. L., Wulf, M. J., Connors, T. M., Jin, Y., Bearoff, F. M., Hai, N., Bouyer, J., Kortagere, S., Zhong, Y., Bethea, J. R., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08237-y · Cited by 7
Metadata
- Authors
- Ulland, T. K., & Colonna, M.
- Affiliations
- University of Wisconsin–Madison (US)
- Washington University in St. Louis (US)
- Corresponding author
- Colonna, Marco
- Venue
- Nature Reviews Neurology
- Published
- 2018-09-28
- Volume
- 14
- Issue
- 11
- Pages
- 667-675
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W2894203109
- Semantic Scholar
- ee2227720d29d3e454a2aa0cfa8d9df4c32b869a
- Cited by
- 735
- References
- 123
- Citations by year
- 2026: 102 · 2025: 115 · 2024: 119 · 2023: 100 · 2022: 117 · 2021: 89 · 2020: 60 · 2019: 29 · 2018: 3
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREM2, Alzheimer's disease, microglia, disease-associated microglia, amyloid plaques, neuroinflammation, late-onset Alzheimer's disease, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Humans, Membrane Glycoproteins, Mutation, Receptors, Immunologic, Amyloid beta-Protein Precursor, Microglia, Presenilins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
